Cocrystal Pharma, Inc. (COCP)
1.21
+0.07
(+6.14%)
USD |
NASDAQ |
Sep 18, 16:00
1.23
+0.02
(+1.65%)
After-Hours: 20:00
Cocrystal Pharma Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | -0.0126M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.0002M |
| September 30, 2024 | 0.0005M |
| June 30, 2024 | 0.0001M |
| March 31, 2024 | -0.008M |
| December 31, 2023 | -0.057M |
| September 30, 2023 | -0.0015M |
| June 30, 2023 | -0.0156M |
| March 31, 2023 | -0.045M |
| December 31, 2022 | -0.0134M |
| September 30, 2022 | -0.0623M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.0066M |
| September 30, 2021 | -0.0038M |
| June 30, 2021 | -0.0153M |
| March 31, 2021 | -0.025M |
| December 31, 2020 | -0.0178M |
| September 30, 2020 | -0.0286M |
| June 30, 2020 | -0.1116M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.093M |
| December 31, 2019 | -0.0017M |
| September 30, 2019 | -0.1142M |
| June 30, 2019 | -0.0041M |
| March 31, 2019 | -0.025M |
| December 31, 2018 | -0.0627M |
| September 30, 2018 | 0.0235M |
| June 30, 2018 | -0.0244M |
| March 31, 2018 | 1.395M |
| December 31, 2017 | 0.0157M |
| September 30, 2017 | -0.0011M |
| June 30, 2017 | -0.0215M |
| March 31, 2017 | -0.033M |
| December 31, 2016 | 0.0338M |
| September 30, 2016 | 0.0219M |
| June 30, 2016 | -0.0539M |
| March 31, 2016 | 0.001M |
| December 31, 2015 | -0.0957M |
| September 30, 2015 | -0.1714M |
| June 30, 2015 | 0.0048M |
| March 31, 2015 | 0.014M |
| December 31, 2014 | 2.470M |
| September 30, 2014 | -0.0205M |
| June 30, 2014 | 2.805M |
| March 31, 2014 | 0.576M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CNBX Pharmaceuticals, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 54.90M |
| Fulcrum Therapeutics, Inc. | 13.78M |
| Definium Therapeutics, Inc. | -315.46M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.536M |
| Free Cash Flow | -8.276M |
| Free Cash Flow Per Share (Quarterly) | -0.1839 |
| Free Cash Flow to Equity (Quarterly) | -2.453M |
| Free Cash Flow to Firm (Quarterly) | -2.536M |
| Free Cash Flow Yield | -52.26% |